Peter Greasley

City:

Molndal

Country:

Sweden

Published Applications:

Last publication date:

2026-01-29

Top Assignees for applications by Peter Greasley

The entities that hold a legal rights for patent applications filed by inventor Greasley Peter:

AstraZeneca AB 7 Sodertalje, Sweden
AstraZeneca AB 1 Sodertaije, Sweden
AstraZeneca A B 1 Sodertalje, Sweden

Recent patent applications by Greasley Peter

Peter Greasley from Molndal, SE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-01-29

US20260027112A1

Human necessities

COMBINATION OF ZIBOTENTAN AND DAPAGLIFLOZIN FOR THE TREATMENT OF ENDOTHELIN RELATED DISEASES

#2 | 2024-10-31

US20240358698A1

Human necessities

COMBINATION OF ZIBOTENTAN AND DAPAGLIFLOZIN FOR THE TREATMENT OF ENDOTHELIN RELATED DISEASES

#3 | 2023-11-16

US20230364077A1

Human necessities

Combination of zibotentan and dapagliflozin for the treatment of endothelin related diseases

#4 | 2022-01-27

US20220023295A1

Human necessities

Combination of zibotentan and dapagliflozin for the treatment of endothelin related diseases

#5 | 2007-05-24

US20070117138A1

Chemistry; metallurgy

SPLICE VARIANT CANNABINOID RECEPTOR (CB1B)

#6 | 2006-08-31

US20060194260A1

Physics

Screening assays for cannabinoid-ligand-type modulators of gpr55

#7 | 2006-06-08

US20060122230A1

Chemistry; metallurgy

1,5-Diaryl-pyrrole-3-carboxamide derivatives and their use as cannabinoid receptor modulators

#8 | 2006-06-08

US20060122229A1

Chemistry; metallurgy

4,5-diarylthiazole derivatives as cb-1 ligands

#9 | 2005-10-27

US20050239133A1

Physics

Methods to identify true antagonists and inverse agonists of the cannabinoid receptor

#10 | 2005-02-10

US20050032808A1

Chemistry; metallurgy

5, 6-diaryl-pyrazine-2-amide derivatives as CBantagonists

InventorID:

4417995 ⎘